SET/TAF-I Antikörper (AA 1-45)
Kurzübersicht für SET/TAF-I Antikörper (AA 1-45) (ABIN1833265)
Target
Alle SET/TAF-I (SET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-45
-
Spezifität
- Human SET
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide corresponding to a region within amino acids 1 and 45 of SET. Percent identity by BLAST analysis: Human, Chicken, Bovine (100%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ICC (1:100 - 1:1000), IHC, IHC-P (1:100 - 1:1000), WB (1:5000 - 1:20000)
Usage: IHC-paraffin: Suggested antigen retrieval using heat mediated 10 mM Citrate buffer ( pH 6.0) or Tris-EDTA buffer ( pH 8.0). -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.0, 10 % glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Keep as concentrated solution. Avoid multiple freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Andere Bezeichnung
- SET / TAF-I
-
Hintergrund
-
Name/Gene ID: SET
Synonyms: SET, 2PP2A, HLA-DR-associated protein II, I-2PP2A, TAF-IBETA, SET nuclear oncogene, TAF-I, Template-activating factor I, I2PP2A, IGAAD, IPP2A2, PHAPII, Protein SET -
Gen-ID
- 6418
-
UniProt
- Q01105
-
Pathways
- Apoptose
Target
-